DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Hanfstein B, Lauseker M, Hehlmann R, Saussele S, Erben P, Dietz C. et al.
Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with Imatinib.
Haematologica 2014;
99: 1441-7
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.